Helix Biomedix Inc (HXBM)
23.27
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Helix Biomedix Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | -1.206 |
| June 30, 2010 | -1.379 |
| March 31, 2010 | -1.532 |
| December 31, 2009 | -1.226 |
| September 30, 2009 | -1.471 |
| June 30, 2009 | -1.862 |
| March 31, 2009 | -2.629 |
| December 31, 2008 | -1.750 |
| September 30, 2008 | -3.506 |
| June 30, 2008 | -30.94 |
| March 31, 2008 | -3.831 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| September 30, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| September 30, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| March 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| September 30, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| March 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| September 30, 2002 | -1.362 |
| June 30, 2002 | -1.758 |
| March 31, 2002 | -2.412 |
| December 31, 2001 | -2.734 |
| September 30, 2001 | -4.110 |
| June 30, 2001 | -10.01 |
| March 31, 2001 | 1.065 |
| December 31, 2000 | 0.8155 |
| September 30, 2000 | 0.6612 |
| June 30, 2000 | 0.5213 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |